Scholar

Sarah Mitchell

H-index: 29
Engineering 40%
Political science 17%
sarahmitchellphd.bsky.social
“One man’s trash is another man’s treasure” 😬

Reposted by: Sarah Mitchell

martinbjensen.bsky.social
US Biotech is #1.
And depends critically on academic research both for trained PhDs to wrestle cures from Nature and for curiosity-driven eurekas (eg CRISPR or statins).

Private industry will not be able to substitute for an enfeebled NIH.

We will have fewer cures and we will lose our primacy.
sethjudson.bsky.social
A whole generation of early career scientists and physician-scientists, including colleagues and myself, are particularly vulnerable to these funding freezes and cuts, with jobs and careers depending on federal grants.

#IDsky
#Medsky
#Episky

www.science.org/content/arti...
U.S. early-career researchers struggling amid chaos
Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard
www.science.org

Reposted by: Sarah Mitchell

mattyousefzadeh.bsky.social
AAV gene therapy for Cockayne syndrome
Cockayne Syndrome (CS) is an autosomal recessive, progressive developmental and neurodegenerative disease. Approximately 30% of cases are caused by mutations in the ERCC8/CSA gene. Patients with CS present with cutaneous photosensitivity, growth failure, shorter life span and a progressive degeneration of the central nervous system. Loss of function mutations in CSA result in deficiencies in transcription-coupled nucleotide excision repair, regulation of RNA Pol II mediated transcription repair of oxidative DNA damage, and mitochondrial metabolism. Currently there are no available therapies for these patients. AAV gene therapy offers an opportunity to address this unmet need. We designed a new AAV vector encoding human CSA under a CBA promoter. We tested the therapeutic efficacy of this AAV9-CSA vector by neonatal ICV injection in the Csa-/-;Xpa-/- mouse model. Treatment with AAV9-CSA resulted in a significant increase in lifespan, and broad distribution of human CSA in the brain and heart. Despite clear therapeutic benefit, we also observed neuroradiological abnormalities, neuropathologic alterations including hypo-myelination, astrocytosis, microgliosis, and likely life limiting transcriptomic alterations in liver at endpoint. Nonetheless, the success of these experiments paves the way for the first in human clinical translation of a gene therapy for CS patients. ### Competing Interest Statement The authors have declared no competing interest.
www.biorxiv.org

Reposted by: Sarah Mitchell

standupforscience.bsky.social
"When you hear about patients surviving stage 4 cancer because of immunotherapy, that was based on NIH research over many decades. When you hear about sickle cell disease being cured because of CRISPR gene editing, that was built on years of research supported by NIH"

apnews.com/article/nih-...
Renowned geneticist Francis Collins retires from NIH, urging 'respect' for embattled workers
Dr. Francis Collins, a renowned geneticist, and former longtime director of the National Institutes of Health, is retiring from the government agency and urging “respect” for its embattled workers.
apnews.com
erictopol.bsky.social
Francis Collins, the NIH Director for 12 years, led the Human Genome Project and other NIH efforts for 32 years, resigned today. Key words from his resignation letter
www.nytimes.com/2025/03/01/u...

Reposted by: Sarah Mitchell

kyledcheney.bsky.social
NEWSY: The White House confirms tonight that Elon Musk is NOT the administrator of DOGE and is not even technically part of it.

He's a "senior adviser to the president" like Anita Dunn, they say. storage.courtlistener.com/recap/gov.us...
warren.senate.gov
Donald Trump and Elon Musk are trying to cut funding for cancer and rare disease research.

A federal judge temporarily blocked the cuts in some states, but this fight is not over.

We can’t let them play politics with our health.
sarahmitchellphd.bsky.social
This!!!!
martinbjensen.bsky.social
US Biotech is #1.
And depends critically on academic research both for trained PhDs to wrestle cures from Nature and for curiosity-driven eurekas (eg CRISPR or statins).

Private industry will not be able to substitute for an enfeebled NIH.

We will have fewer cures and we will lose our primacy.
repcasar.bsky.social
How much Elon Musk makes from the government a day: $8 million.

How much a senior on Social Security gets a day: $65

Guess which budget Musk and Trump want to cut?
standupforscience.bsky.social
Welcome to the Bluesky account for Stand Up for Science 2025!

Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide!

#scienceforall #sciencenotsilence

Reposted by: Sarah Mitchell

blekhman.bsky.social
Government isn't a business. The goal isn't to save money. Success isn't measured by budget surplus.

The goal is to spend money, investing in society. Every dollar spent on education, healthcare, and science is an investment in our collective wellbeing.
sarahmitchellphd.bsky.social
Ugh. I hope they don’t pull funding from funded K99 MOSIAC peeps. It would be terrible if they suddenly couldn’t get their R00 phase money.

Reposted by: Sarah Mitchell

mblscience.bsky.social
Exciting news! MBL has received a $2.6M gift from an anonymous donor! This generous support fuels our mission of discovery, education, and innovation. Private philanthropy drives groundbreaking research and shapes the future of science. 🌎🔬 #ScienceStartsHere #Philanthropy
A drone picture of the Lillie Building at the Marine Biological Laboratory
jcyaroch.bsky.social
Today is Retraction Day, when we observe the anniversary of the retraction (Feb. 2, 2010) of the fraudulent paper that purported to show a link between vaccines and autism. 🧪#medsky
This is the front page of a fraudulent research article that purported to show a link between vaccines and autism. The word "RETRACTED" is written across it in large red letters. 

Wikipedia: On 28th February 1998, a fraudulent research paper by physician Andrew Wakefield and twelve coauthors, titled "Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children", was published in the British medical journal The Lancet.[1] The paper falsely claimed causative links between the measles, mumps, and rubella (MMR) vaccine and colitis and between colitis and autism. The fraud involved data selection, data manipulation, and two undisclosed conflicts of interest.

References

Fields & subjects

Updated 1m